Eve Investments delivers on expansion promises with Whole Foods roll out
Health & Biotech
Health & Biotech
Link copied to
Eve Investments (ASX:EVE) has confirmed its roll out into American multinational supermarket chain Whole Foods with two products to be ranged in all 48 stores in Whole Foods’ North Western California network.
The products will launch in stores by the end of June, expanding on Eve’s strong position in the US where it has already had great success selling on Amazon.
Eve Investments initially advised in January that it had reached an agreement with Whole Foods for its Meluka Australia Organic Raw Native Honey and Organic Raw Native Honey infused with Tea Tree. Orders of the products will be continued on an ongoing basis as is traditional in the industry.
On top of its success and growth in the US, Eve is also anticipating its first shipment into Japan will clear customs this week. The products will be sold via Japan Amazon and are anticipated to be live by the end of the month.
Eve has already had extensive success with its products on Amazon and Japan will be the fourth consumer market the company sells in via the platform, following Australia, the US and Canada.
Eve’s Native Raw Honey is consistently ranked the number on honey on Amazon Australia and in the top three within the entire grocery category. Eve plans to continue this success in its other markets in the coming months.
Eve’s Meluka Australia will also launch two new products in April, including an Apple Cider Vinegar infused with Raw Honey and a Raw Honey Probiotic Concentrate with Tea Tree, which will then launch internationally in the next quarter. New product development is ongoing across the honey and beverage product lines, with further new product launches expected in the second half of 2021.
In its December 2020 quarterly update, Eve reported strong sales in the US and Australia and increasing demand for its raw honey in China, with group unaudited revenues of $1.9 million. Thanks to the Whole Foods order and the Amazon expansion, Eve is anticipating continued success in its next reporting and into FY21.